PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1777132
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1777132
The medical coating market is expected to reach USD 15,813.6 million by 2030, up from USD 9,983.0 million in 2025, growing at a CAGR of 9.6%.
Scope of the Report | |
---|---|
Years Considered for the Study | 2022-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Kilotons; Value (USD Million) |
Segments | Coating Type, Material, Substrate, and Application |
Regions covered | Asia Pacific, North America, Europe, Middle East & Africa, and South America |
The rising demand for medical devices in the healthcare sector significantly drives the growth of the medical coating market, as coatings continue to evolve and become crucial for the safety, performance, and durability of devices. An aging population and a higher prevalence of chronic diseases create a greater need for coated devices such as implants, catheters, and surgical instruments, thereby supporting market growth and fostering innovation.
"Based on application, medical devices will be the largest application in the medical coating market during the forecast period, in terms of value."
The medical devices application segment is projected to be the largest in the medical coating market by value during the forecast period due to the widespread and increasing use of coated devices across all organizations and healthcare settings. The adoption of various coated medical devices is mainly driven by the rising rates of chronic diseases, the growing aging global population, and advancements in minimally invasive surgical procedures, all of which require performance-enhanced, safer, and easier-to-use medical devices. Medical coatings are vital for many devices, including catheters, stents, guidewires, orthopedic implants, and surgical instruments, as they offer superior lubricity, biocompatibility, and antimicrobial properties. These coatings reduce friction, minimizing tissue trauma, lower infection risks, and improve device performance and shelf-life. Additionally, the rise in hospital-acquired infections has made antimicrobial and anti-thrombogenic coatings essential for patient safety and meeting strict regulatory standards. Innovations in medical technology, such as imaging systems and precision instruments, have significantly increased the demand for high-performance medical coatings to achieve more accurate and less traumatic surgical outcomes. Therefore, the medical devices segment is expected to continue its growth.
"Based on coating type, active coating will be the fastest in the medical coating market during the forecast period, in terms of value."
Active coatings are the fastest-growing type of coating by value in the medical coating market during the forecast period, due to their specialized therapeutic capabilities compared to passive coatings and the increasing demand for innovative solutions to improve patient safety and clinical outcomes. While passive coatings only provide surface protection during use (such as protection and lubrication), active coatings are engineered to release drugs, antimicrobial agents, or bioactive molecules at the application site. This delivery method is essential for high-risk medical devices (like stents, catheters, and orthopedic implants) where infection, thrombosis, and inflammation threaten successful patient management. The rise in hospital-acquired infections and the worldwide increase in chronic diseases and comorbidities expose chronic patients to higher infection risks, as post-surgical complications-such as PMN-mediated inflammation and infections-lead to extended risks and costs. Therefore, hospitals and healthcare providers are seeking more effective coatings that reduce the risk of hospital-acquired infections and promote faster recovery.
"Based on region, North America accounts for the largest share in the medical coating market, in terms of value."
North America is the largest and fastest-growing region in the medical coating market, with value growth driven by advanced healthcare delivery systems, an increase in procedures performed, and a strong commitment to the continuous development of medical devices. North America, especially the United States, hosts many top medical device manufacturers and research institutions that are innovating the next generation of coatings for applications such as cardiovascular stents, orthopedic implants, catheters, and surgical instruments. Additionally, the rising demand for medical coatings in North America is linked to a growing and aging population with increasing rates of chronic diseases, as well as a heightened focus on infection control and patient safety, which demand sophisticated, biocompatible, and antimicrobial coatings.
The key players in this market are Hydromer (US), DSM-Firmenich (Netherlands), Surmodics (US), Biocoat Incorporated (US), AST Products Inc (US), Covalon Technologies (Canada), Freudenberg Medical (US), Harland Medical Systems, Inc (US), Merit Medical Systems (US), Applied Medical Coatings (US), PPG Industries, Inc. (US) and The Sherwin-Williams Company (US).
Research Coverage
This report breaks down the medical coating market by coating type, material, substrate, application, and region, and provides estimates for the total market value across different regions. A thorough analysis of major industry players has been carried out to offer insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions related to the medical coating market.
Key benefits of buying this report
This research report covers different levels of analysis, including industry examination (industry trends), market ranking analysis of leading players, and company profiles. Together, these provide a comprehensive view of the competitive landscape, emerging and high-growth segments of the medical coating market, high-growth regions, and market drivers, restraints, opportunities, and challenges.